CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics

CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) in China

CANbridge Life Sciences Appoints Chief Medical Officer

CANbridge Life Sciences Appoints Vice President of Clinical Development and Medical Affairs and Director of Quality Assurance

CANbridge Receives China Food and Drug Administration Approval for CAN002 as Cancer Adjuvant Therapy

CANbridge Receives Approval to Commence CAN008 Phase II/III Trial in Glioblastoma Multiforme (Gbm) in China

Industry Veteran Joins CANbridge Life Sciences Advisory Team

Puma Biotechnology and CANbridge Life Sciences Enter into Exclusive Licensing Agreement to Commercialize Nerlynx® (Neratinib) in Greater China

CANbridge Appoints Sunny Zhang as Vice President of Regulatory Affairs and Quality